EN
抗体药类似物
Research Grade Sotatercept
All
TD-HY428026_1.jpg
  • CatalogTD-HY428026
  • Clonality
  • Application Research Grade Biosimilar
  • SynonymsACE-011,ACTRIIA-Fc,MK7962,MK-7962,MK7962,Sotatercept(USAN/INN),SOTATERCEPT-CSRK,WINREVAIR,CAS:1001080-50-7
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Sotatercept


Catalog No. TD-HY428026
Species reactivity Human
Applications Research Grade Biosimilar
Isotype Fusion - [ACVR2A (activin A receptor type 2A, ActR-II, ActRIIA)]2 - IGHG1 Fc (Fragment constant)
Expression system Mammalian Cells
Target EDF, Erythroid differentiation protein, Activin beta-A chain, INHBA, Inhibin beta A chain
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P08476
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names ACE-011,ACTRIIA-Fc,MK7962,MK-7962,MK7962,Sotatercept(USAN/INN),SOTATERCEPT-CSRK,WINREVAIR,CAS:1001080-50-7
Background Sotatercept (ACE-011) is a soluble activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY428026_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Sotatercept